米非司酮配伍依沙吖啶用于瘢痕子宫中晚期妊娠引产的安全性和有效性.docVIP

米非司酮配伍依沙吖啶用于瘢痕子宫中晚期妊娠引产的安全性和有效性 　　摘要：目的： 探究临床上应用米非司酮配伍依沙吖啶对瘢痕子宫中晚期妊娠的孕妇进行引产的安全性和有效性。方法： 选取2012年8月―2014年8月我院收治住院并要求终止妊娠的瘢痕子宫中晚期妊娠患者78例，随机将其分为对照组和观察组，每组34例，对照组采用羊膜腔内注射依沙吖啶进行引产，观察组采用米非司酮配伍依沙吖啶进行引产，观察两组引产的成功率、效果、不良反应以及引产后并发症的情况，并进行统计学比较。结果： 观察组的引产成功率比对照组高，宫缩发动的时间和从宫缩发动到胎盘娩出的时间均比对照组短，胎盘残留率和阴道出血量均比对照组低。结论： 米非司酮配伍依沙吖啶对瘢痕子宫中晚期妊娠的孕妇进行引产成功率高、安全性好、无不良反应、并发症少，给患者带来的痛苦小，是一种比较理想的治疗方法。 　　关键词：瘢痕子宫中晚期妊娠；引产；米非司酮；依沙吖啶 　　Abstract ： objective to explore the clinical application of mifepristone compatibility in accordance with the sand acridine scar uterus middle-late pregnancy pregnant women in induced labor safety and effectiveness. Method selection in August 2012 - August 2014 our hospital in the hospital and request to terminate the pregnancy scar uterus middle-late pregnancy， 78 cases of patients， randomly divided into control group and observation group， 34 cases in each group， control group adopts the amniotic cavity injection of induced labor in accordance with the sand acridine， observation group with mifepristone compatibility in accordance with the sand acridine induced labor， observe the success rate of two groups of preterm delivery， effect， adverse reaction and complications after induced labor， and statistical comparison. Results observation group induced labor success rate higher than the control group， contractions start time and from the contractions start time to the placenta are shorter than the control group， placental retention rate and vaginal haemorrhage amount was lower than control group. Conclusion mifepristone compatibility on sand acridine scar uterus middle-late pregnancy pregnant women an elective high success rate， good security and no adverse reaction， fewer complications， to the pain of patients with small， is an ideal treatment method. 　　Keywords： scar uterus middle-late pregnancy； Induced labor； Mifepristone； According to the sand acridine 　　瘢痕子宫是指，既往的子宫手术或者组织修复等在子宫上留下的瘢痕，临床上常见于剖宫产、肌瘤剔除等治疗后，以剖宫产术后最多见[1]。而随着我国剖宫产率的不断上升，剖宫产术后因避孕不佳导致的再次妊娠的几率也增加了，